Literature DB >> 15088696

Semecarpus anacardium L, nuts inhibit lipopolysaccharide induced NO production in rat macrophages along with its hypolipidemic property.

Y B Tripathi1, R S Pandey.   

Abstract

Traditionally S. anacardium is used for rejuvenation, rheumatoid arthritis, fever and neurological disorders. In the present study it was observed that a fraction of S. anacacrdium at dose of 1 mg/100 g body wt, significantly reduced serum cholesterol from 378.87 mg/dl in the rats fed with atherogenic diet (AD) to 197.99 mg/dl (45-52%) in the rats fed with AD diet and increased serum HDL-cholesterol (33-37%). The same fraction also inhibited LPS induced NO production in the culture activated rat peritoneal macrophages in the dose dependent manner with IC50 value at 50 ng/ml of the culture medium. The drug in the above doses was completely safe and non-toxic, (no change in the enzymes), to liver and kidney functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15088696

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  5 in total

1.  Hypolipidemic activity of Semecarpus anacardium in Streptozotocin induced diabetic rats.

Authors:  Aseervatham Jaya; Palanivelu Shanthi; Panchanatham Sachdanandam
Journal:  Endocrine       Date:  2010-06-24       Impact factor: 3.633

2.  Effect of hexane fraction of leaves of Cinnamomum tamala Linn on macrophage functions.

Authors:  J K Chaurasia; Nidhi Pandey; Yamini Bhushan Tripathi
Journal:  Inflammopharmacology       Date:  2010-01-14       Impact factor: 4.473

3.  Role of Sandhika: a polyherbal formulation on MC3T3-E1 osteoblast-like cells.

Authors:  Yamini B Tripathi; Pratibha Tripathi; Kiranmayi Korlagunta; Sheau Ching Chai; Brenda J Smith; Bahram H Arjmandi
Journal:  Inflammation       Date:  2008-02       Impact factor: 4.092

4.  Analgesic activity and acute toxicity study of Semecarpus anacardium stem bark extracts using mice.

Authors:  G M Lingaraju; H Joy Hoskeri; V Krishna; P Suresh Babu
Journal:  Pharmacognosy Res       Date:  2011-01

5.  BHUx: A Patent Polyherbal Formulation to Prevent Atherosclerosis.

Authors:  Yamini B Tripathi; Birendra K Singh; Ravi S Pandey; Mohan Kumar
Journal:  Evid Based Complement Alternat Med       Date:  2005-06       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.